• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Medical Resources completes debt accord

Article

Imaging services provider Medical Resources of Hackensack, NJ, has completed an agreement with a group of corporate bond holders that restructures the terms of senior notes held by the investors. Medical Resources had fallen into technical default on the

Imaging services provider Medical Resources of Hackensack, NJ, has completed an agreement with a group of corporate bond holders that restructures the terms of senior notes held by the investors. Medical Resources had fallen into technical default on the notes because of covenants that required it to maintain a certain level of net income (SCAN 9/2/98).

Under the restructured deal, the bond holders agreed to waive the company’s defaults and modify the terms of the notes to relax the net income provisions. Medical Resources has agreed to prepay $2 million in principal out of a total of $78 million, issue stock purchase warrants to the note holders, and pay a higher interest rate on the notes.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.